Summary
Glycosphingolipid (GSL) storage diseases (GSDs) are a group of monogenic disorders among a large family of lysosomal storage diseases, which include more than 40 different human disorders. GSDs are caused by the impaired catalytic activity of the lysosomal hydrolases responsible for GSL degradation, which leads to accumulation of undegraded GSLs in lysosomes. The clinical presentation of GSDs varies between disorders and within each disorder. The reason for this heterogeneity is not known, but almost certainly depends on the level and nature of the accumulating GSL and the down-stream biochemical and cellular pathways activated upon GSL accumulation. We now review what little is known about the correlation of the clinical progression and pathology with the underlying biochemistry of the GSDs.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
4. References
Bodennec, J., Pelled, D., Riebeling, C., Trajkovic, S., and Futerman, A. H. (2002). Phosphatidylcholine synthesis is elevated in neuronal models of Gaucher disease due to direct activation of CTP: phosphocholine cytidylyltransferase by glucosylceramide. Faseb J, 16, 1814–1816.
Buccoliero, R., Bodennec, J., Van Echten-Deckert, G., Sandhoff, K., and Futerman, A. H. (2004). Phospholipid synthesis is decreased in neuronal tissue in a mouse model of Sandhoff disease. J Neurochem, 90, 80–88.
Buccoliero, R., and Futerman, A. H. (2003). The roles of ceramide and complex sphingolipids in neuronal cell function. Pharmacol Res, 47, 409–419.
Chen, C. S., Patterson, M. C., Wheatley, C. L., O’Brien, J. F., and Pagano, R. E. (1999). Broad screening test for sphingolipid-storage diseases. Lancet, 354, 901–905.
Finn, L. S., Zhang, M., Chen, S. H., and Scott, C. R. (2000). Severe type II Gaucher disease with ichthyosis, arthrogryposis and neuronal apoptosis: molecular and pathological analyses. Am J Med Genet, 91, 222–226.
Futerman, A. H., and van Meer, G. (2004). The cell biology of lysosomal storage disorders. Nat Rev Mol Cell Biol, 5, 554–565.
Ginzburg, L. and Futerman, A.H. Defective calcium homeostasis in the cerebellum in a mouse model of Niemann-Pick A disease. Submitted for publication.
Jaiswal, J. K., Andrews, N. W., and Simon, S. M. (2002). Membrane proximal lysosomes are the major vesicles responsible for calcium-dependent exocytosis in nonsecretory cells. J Cell Biol, 159, 625–635.
Jatana, M., Giri, S., and Singh, A. K. (2002). Apoptotic positive cells in Krabbe brain and induction of apoptosis in rat C6 glial cells by psychosine. Neurosci Let, 330, 183–187.
Jeyakumar, M., Butters, T. D., Cortina-Borja, M., Hunnam, V., Proia, R. L., Perry, V. H., Dwek, R. A., and Platt, F. M. (1999). Delayed symptom onset and increased life expectancy in Sandhoff disease mice treated with N-butyldeoxynojirimycin. Proc Natl Acad Sci U S A, 96, 6388–6393.
Jeyakumar, M., Thomas, R., Elliot-Smith, E., Smith, D. A., van der Spoel, A. C., d’Azzo, A., Perry, V. H., Butters, T. D., Dwek, R. A., and Platt, F. M. (2003). Central nervous system inflammation is a hallmark of pathogenesis in mouse models of GM1 and GM2 gangliosidosis. Brain, 126, 974–987.
Kaneko, M., and Nomura, Y. (2003). ER signaling in unfolded protein response. Life Sci, 74, 199–205.
Korkotian, E., Schwarz, A., Pelled, D., Schwarzmann, G., Segal, M., and Futerman, A. H. (1999). Elevation of intracellular glucosylceramide levels results in an increase in endoplasmic reticulum density and in functional calcium stores in cultured neurons. J Biol Chem, 274, 21673–21678.
Lachmann, R. H. (2003). Miglustat. Oxford GlycoSciences/Actelion. Curr Opin Investig Drugs, 4, 472–479.
Ledeen RW, W. G. (1992). Ganglioside function in the neuron. Trends Glycosci Glycotechnol, 4, 174–187.
Linke, M., Herzog, V., and Brix, K. (2002). Trafficking of lysosomal cathepsin B-green fluorescent protein to the surface of thyroid epithelial cells involves the endosomal/lysosomal compartment. J Cell Sci, 115, 4877–4889.
Lloyd-Evans, E., Pelled, D., Riebeling, C., Bodennec, J., de-Morgan, A., Waller, H., Schiffmann, R., and Futerman, A. H. (2003a). Glucosylceramide and glucosylsphingosine modulate calcium mobilization from brain microsomes via different mechanisms. J Biol Chem, 278, 23594–23599.
Lloyd-Evans, E., Pelled, D., Riebeling, C., and Futerman, A. H. (2003b). Lyso-glycosphingolipids mobilize calcium from brain microsomes via multiple mechanisms. Biochem J, 375, 561–565.
Marks, D. L., and Pagano, R. E. (2002). Endocytosis and sorting of glycosphingolipids in sphingolipid storage disease. Trends Cell Biol, 12, 605–613.
Meikle, P. J., Hopwood, J. J., Clague, A. E., and Carey, W. F. (1999). Prevalence of lysosomal storage disorders. JAMA, 281, 249–254.
Myerowitz, R., Lawson, D., Mizukami, H., Mi, Y., Tifft, C. J., and Proia, R. L. (2002). Molecular pathophysiology in Tay-Sachs and Sandhoff diseases as revealed by gene expression profiling. Hum Mol Genet, 11, 1343–1350.
Pelled, D., Lloyd-Evans, E., Riebeling, C., Jeyakumar, M., Platt, F. M., and Futerman, A. H. (2003a). Inhibition of calcium uptake via the sarco/endoplasmic reticulum Ca2+-ATPase in a mouse model of Sandhoff disease and prevention by treatment with N-butyldeoxynojirimycin. J Biol Chem, 278, 29496–29501.
Pelled, D., Riebeling, C., van Echten-Deckert, G., Sandhoff, K., and Futerman, A. H. (2003b). Reduced rates of axonal and dendritic growth in embryonic hippocampal neurones cultured from a mouse model of Sandhoff disease. Neuropathol Appl Neurobiol, 29, 341–349.
Pelled, D., Shogomori, H., and Futerman, A. H. (2000). The increased sensitivity of neurons with elevated glucocerebroside to neurotoxic agents can be reversed by imiglucerase. J Inherit Metab Dis, 23, 175–184.
Pelled, D., Trajkovic-Bodennec, S., Lloyd-Evans, E., Sidransky, E., Schiffmann, R., and Futerman, A. H. (2005). Enhanced calcium release in the acute neuronopathic form of Gaucher disease. Neurobiol Dis, 18, 83–88.
Raas-Rothschild, A., Pankova-Kholmyansky, I., Kacher, Y., and Futerman, A. H. (2004). Glycosphingolipidoses: beyond the enzymatic defect. Glycoconj J, 21, 295–304.
Rutkowski, D. T., and Kaufman, R. J. (2004). A trip to the ER: coping with stress. Trends Cell Biol, 14, 20–28.
Sillence, D. J., and Platt, F. M. (2003). Storage diseases: new insights into sphingolipid functions. Trends Cell Biol, 13, 195–203.
Tardy, C., Andrieu-Abadie, N., Salvayre, R., and Levade, T. (2004). Lysosomal storage diseases: is impaired apoptosis a pathogenic mechanism? Neurochem Res, 29, 871–880.
Tessitore, A., del, P. M. M., Sano, R., Ma, Y., Mann, L., Ingrassia, A., Laywell, E. D., Steindler, D. A., Hendershot, L. M., and d’Azzo, A. (2004). GM1-ganglioside-mediated activation of the unfolded protein response causes neuronal death in a neurodegenerative gangliosidosis. Mol Cell, 15, 753–766.
Trajkovic-Bodennec, S., Bodennec, J., and Futerman, A. H. (2004). Phosphatidylcholine metabolism is altered in a monocyte-derived macrophage model of Gaucher disease but not in lymphocytes. Blood Cells Mol Dis, 33, 77–82.
Wada, R., Tifft, C. J., and Proia, R. L. (2000). Microglial activation precedes acute neurodegeneration in Sandhoff disease and is suppressed by bone marrow transplantation. Proc Natl Acad Sci U S A, 97, 10954–10959.
Walkley, S. U. (1998). Cellular pathology of lysosomal storage disorders. Brain Pathol, 8, 175–193.
Walkley, S. U. (2004). Secondary accumulation of gangliosides in lysosomal storage disorders. Semin Cell Dev Biol, 15, 433–444.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer-Verlag Tokyo
About this chapter
Cite this chapter
Kacher, Y., Futerman, A.H. (2006). Neuronal Cell Death in Glycosphingolipidoses. In: Hirabayashi, Y., Igarashi, Y., Merrill, A.H. (eds) Sphingolipid Biology. Springer, Tokyo. https://doi.org/10.1007/4-431-34200-1_22
Download citation
DOI: https://doi.org/10.1007/4-431-34200-1_22
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-34198-7
Online ISBN: 978-4-431-34200-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)